Arne Akbar is Professor of Immunology at University College London. He is internationally recognized for his studies on mechanisms that control the differentiation and senescence of human T lymphocytes. His group was one of the first to identify human regulatory T cells. He was closely involved in the development of Simulect used for the prevention of acute solid organ graft rejection that has been used to treat ~300,000 patients worldwide. His work involves studies at the interface between academia, industry and clinical practice. He is poised to deliver high impact translational insight into enhancing immunity during ageing that has global relevance.
Fellow
Back to directory listingProfessor Arne Akbar FMedSci
Job Title
Professor of Immunology
Department
Infection and Immunity
Institution
University College London (UCL)
Year elected
2016
Interests
Specialitiesimmunity and ageing. human immunology, mechanisms of immunosenescence. interventions to enhance immunity.
Section committee elected byCellular and developmental biology, microbiology and immunology, genetics